Literature DB >> 12440270

Seroepidemiology of toxoplasmosis among HIV-infected patients and healthy blood donors.

V Nissapatorn1, A Kamarulzaman, I Init, L H Tan, M Rohela, A Norliza, L L Chan, H M Latt, A Khairul Anuar, K F Quek.   

Abstract

A cross-sectional study was carried out in University of Malaya Medical Centre, Kuala Lumpur. Blood samples from 100 HIV-infected patients and 203 Healthy Blood Donors (HBD) were collected and anti-Toxoplasma antibodies were detected by using conventional ELISA. The seroprevalence of toxoplasmosis in HIV/AIDS and Healthy Blood Donors were found to be 21% and 28.1% respectively. There was no significant association between the seroprevalence of toxoplasmosis and various possible risk factors i.e. contact with cat, consumption of undercooked meat and history of blood transfusion in both groups. No significant differences between Toxoplasma seroprevalence in HIV/AIDS and Healthy Blood Donors in association with presence of single or multiple risk factors were found. The mean CD4 count among HIV/AIDS patients in this study was 202.23 cell/cumm. There was no significant association between CD4 count and seropositivity for Toxoplasma antibodies in HIV/AIDS patients.

Entities:  

Mesh:

Year:  2002        PMID: 12440270

Source DB:  PubMed          Journal:  Med J Malaysia        ISSN: 0300-5283


  18 in total

1.  Seroprevalence of and risk factors for Toxoplasma gondii antibodies among asymptomatic blood donors in Egypt.

Authors:  Hany M Elsheikha; Manar S Azab; Nashwa K Abousamra; Mohammad H Rahbar; Doaa M Elghannam; Douaa Raafat
Journal:  Parasitol Res       Date:  2009-02-06       Impact factor: 2.289

2.  Seroprevalence and sources of toxoplasmosis among Orang Asli (indigenous) communities in Peninsular Malaysia.

Authors:  Romano Ngui; Yvonne A L Lim; Noor Farah Hani Amir; Veeranoot Nissapatorn; Rohela Mahmud
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

3.  Seroprevalence and Associated Risk Factors for Toxoplasma gondii Infections Among Urban Poor Communities in Peninsular Malaysia.

Authors:  Norhidayu Sahimin; Izzah Ruzana Mohd Hanapi; Zarin Amalina Nurikhan; Jerzy M Behnke; Siti Nursheena Mohd Zain
Journal:  Acta Parasitol       Date:  2020-11-21       Impact factor: 1.440

4.  Comparative study on toxoplasma serology among HIV positive and HIV negative illicit drug users in Ahvaz, Iran.

Authors:  Seyed Mohammad Alavi; Ramin Jamshidian; Shokrolah Salmanzadeh
Journal:  Caspian J Intern Med       Date:  2013

Review 5.  Toxoplasma gondii infection in humans in China.

Authors:  Peng Zhou; Zhaoguo Chen; Hai-Long Li; Haihong Zheng; Shenyi He; Rui-Qing Lin; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2011-08-24       Impact factor: 3.876

6.  Anti-Toxoplasma gondii Antibody Levels in Blood Supply of Shiraz Blood Transfusion Institute, Iran.

Authors:  Minoo Shaddel; Iraj Mirzaii-Dizgah; Mehran Hoshangi
Journal:  Iran J Parasitol       Date:  2014-03       Impact factor: 1.012

7.  Sero-prevalence of latent Toxoplasma gondii infection among HIV-infected and HIV-uninfected people in Addis Ababa, Ethiopia: A comparative cross-sectional study.

Authors:  Techalew Shimelis; Mekashaw Tebeje; Endale Tadesse; Belete Tegbaru; Ashenafi Terefe
Journal:  BMC Res Notes       Date:  2009-10-23

8.  Seroepidemiology of Toxoplasma gondii Infection among healthy blood donors in Taiwan.

Authors:  Ting-Yi Chiang; Hwei-Ho Hsieh; Ming-Chu Kuo; Kai-Tse Chiu; Wei-Chen Lin; Chia-Kwung Fan; Chi-Tai Fang; Dar-Der Ji
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

9.  Seroprevalence and risk factors for Toxoplasmosis in HIV infected and non-infected individuals in Bahir Dar, Northwest Ethiopia.

Authors:  Fisseha Walle; Nigatu Kebede; Aster Tsegaye; Tesfu Kassa
Journal:  Parasit Vectors       Date:  2013-01-16       Impact factor: 3.876

10.  Seroepidemiology of infection with Toxoplasma gondii in healthy blood donors of Durango, Mexico.

Authors:  Cosme Alvarado-Esquivel; Miguel Francisco Mercado-Suarez; Alfredo Rodríguez-Briones; Laura Fallad-Torres; Julio Octavio Ayala-Ayala; Luis Jorge Nevarez-Piedra; Ehecatl Duran-Morales; Sergio Estrada-Martínez; Oliver Liesenfeld; José Angel Márquez-Conde; Sergio Arturo Martínez-García
Journal:  BMC Infect Dis       Date:  2007-07-13       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.